Kohara, M., Masuda, T., Shiizaki, K., Akimoto, T., Watanabe, Y., Honma, S., . . . Nagata, D. (2017). Association between circulating fibroblast growth factor 21 and mortality in end-stage renal disease. PLoS One.
Citación estilo ChicagoKohara, Marina, et al. "Association between Circulating Fibroblast Growth Factor 21 and Mortality in End-stage Renal Disease." PLoS One 2017.
Cita MLAKohara, Marina, et al. "Association between Circulating Fibroblast Growth Factor 21 and Mortality in End-stage Renal Disease." PLoS One 2017.
Precaución: Estas citas no son 100% exactas.